Q-LINE BIOTECH LIMITED

21 May 2026 - 25 May 2026 Individual Category SME NSE

Min Investment

₹274400

Price Band

₹326-₹343

Issue Size

₹153.39 Cr

Lot Size

400 (per lot)

IPO Dates
img

21 May 2026

Open Date

img

25 May 2026

Close Date

img

26 May 2026

Allotment Date

img

29 May 2026

Listing Date

Know Before Investing

Strengths icon

  • Q-Line Biotech has established manufacturing capabilities with a focus on R&D and quality control.
  • The company offers a diversified product portfolio across multiple IVD segments.
  • It has a widespread distribution network across all four regions of India.
  • The company has long-standing relationships with customers in the diagnostics industry.
  • Q-Line Biotech has shown a track record of healthy financial performance.

Weaknesses icon

  • Any disruption at its manufacturing or R&D facilities could affect operations and revenue.
  • The company depends on third-party suppliers for key raw materials and equipment.
  • A large share of revenue comes from a few major customers.
  • Failure to maintain product quality could lead to recalls, penalties, or reputational damage.
  • Delays in regulatory approvals or registrations may impact business operations.

About Q-line Biotech Limited

Q-Line Biotech Limited is an in-vitro diagnostics (IVD) company engaged in the manufacturing and trading of biochemistry reagents, diagnostic instruments and consumables used in healthcare testing and laboratory applications. The company operates multiple manufacturing facilities in Uttar Pradesh and Delhi and offers products across categories such as ELISA, molecular diagnostics, chemiluminescence immunoassay (CLIA), immuno fluorescence assay (IFA), nucleic acid extraction kits and PCR-based diagnostic kits. Its product portfolio includes tests for infectious diseases, thyroid disorders, cardiac markers and other clinical conditions. The company generates revenue primarily through the sale of its diagnostic products and instruments, largely through a network of distributors, including group entity POCT Services. Q-Line Biotech also focuses on research and development through its subsidiary, Q-Line Innovations Private Limited, which works on developing diagnostic and scientific equipment and consumables.

IPO Objectives

1. 1) To meet Working Capital requirements2) Repayment of certain borrowing availed by our Company, in part or full3) General Corporate Purpose.

Company Promoters

Abhay Agrawal

Ajay Kumar Mahanty

Amita Garg

Ayush Garg

Saurabh Garg

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account